Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches

Background: Coronavirus (CoV) is an emerging human pathogen causing severe acute respiratory syndrome (SARS) around the world. Earlier identification of biomarkers for SARS can facilitate detection and reduce the mortality rate of the disease. Thus, by integrated network analysis and structural mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvaraj, Gurudeeban, Kaliamurthi, Satyavani, Peslherbe, Gilles H., Wei, Dong-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080978/
https://www.ncbi.nlm.nih.gov/pubmed/33968364
http://dx.doi.org/10.12688/f1000research.50850.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080978/
https://www.ncbi.nlm.nih.gov/pubmed/33968364
http://dx.doi.org/10.12688/f1000research.50850.3

Ejemplares similares